Patrys Ltd has released a press release.
Patent Granted for Pre-clinical IgM Candidate PAT-LM1
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Patrys
- Appendix 4C - Quarterly - 30 June 2018
- Preliminary PAT-DX1 pharmacokinetics
- China and Japan both grant patents for Deoxymab 3E10
- PAT-DX1 Targets and Kills Brain Cancer Stem Cells
- Patrys Increases Capital Raising to $4.6 million
Later from Patrys
- Appendix 4E and 2018 Annual Report
- Patrys and WEHI Awarded Grant
- PAT-DX1 Clinical Target Indications Confirmed
- Settlement of Manufacturing Claims
- Appendix 4C - Quarterly - 30 September 2018
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys